You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Antimicrobial prophylaxis received versus ciprofloxacin resistance status

From: Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial

Drug received N = 510 Ciprofloxacin-susceptible 430, (84.3%) Ciprofloxacin-resistant 80, (16.3%)
Amikacin 0 2 (2.5)
Aztreonam 0 1 (1.2)
Bactrim 0 23 (28.8)
Bactrim + Gentamicin 0 1(1.2)
Bactrim + Meropenem 0 1 (1.2)
Ceftriaxone 0 3 (3.8)
Cefuroxime 0 38 (47.5)
Ciprofloxacin 406 (94.4) 0
Ciprofloxacin + Amoxicillin 3 (0.7) 0
Ciprofloxacin + Gentamicin 21 (4.9) 0
Ertapenem 0 4 (5.0)
Gentamicin 0 7 (8.8)